dna-c2
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2011 (NCT01418235)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dna-c2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01418235 | Phase 1 | Jun 1, 2011 | Aurum Institute, HIV Vaccine Trials Network, South Africa AIDS Vaccine Initiative |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aurum Institute | Academic/Hospital | 1 | 0 | 1 | 2011 |
| HIV Vaccine Trials Network | Academic/Hospital | 1 | 1 | 1 | 2011 |
| South Africa AIDS Vaccine Initiative | Academic/Hospital | 1 | 0 | 1 | 2011 |
3 organizations
Page 1 / 1